Cite
HARVARD Citation
Deben, C. et al. (2016). TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value. Critical reviews in oncology/hematology. pp. 63-73. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Deben, C. et al. (2016). TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value. Critical reviews in oncology/hematology. pp. 63-73. [Online].